AQR Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Sell |
398,232
-93,529
| -19% | -$2.59M | 0.01% | 937 |
|
|
2025
Q1 | $10.9M | Buy |
491,761
+294,319
| +149% | +$6.54M | 0.01% | 847 |
|
|
2024
Q4 | $3.91M | Buy |
197,442
+13,273
| +7% | +$263K | 0.01% | 1211 |
|
|
2024
Q3 | $4.6M | Buy |
184,169
+58,174
| +46% | +$1.45M | 0.01% | 1096 |
|
|
2024
Q2 | $2.35M | Sell |
125,995
-33,328
| -21% | -$622K | ﹤0.01% | 1386 |
|
|
2024
Q1 | $3.14M | Sell |
159,323
-68,722
| -30% | -$1.36M | 0.01% | 1211 |
|
|
2023
Q4 | $4M | Sell |
228,045
-95,533
| -30% | -$1.68M | 0.01% | 1045 |
|
|
2023
Q3 | $5.62M | Sell |
323,578
-187,444
| -37% | -$3.26M | 0.01% | 868 |
|
|
2023
Q2 | $7.2M | Buy |
511,022
+103,260
| +25% | +$1.45M | 0.02% | 761 |
|
|
2023
Q1 | $4.39M | Buy |
407,762
+262,747
| +181% | +$2.83M | 0.01% | 950 |
|
|
2022
Q4 | $2.17M | Buy |
+145,015
| New | +$2.17M | ﹤0.01% | 1218 |
|
|
2021
Q1 | – | Sell |
-15,390
| Closed | -$272K | – | 2232 |
|
|
2020
Q4 | $272K | Sell |
15,390
-2,868
| -16% | -$50.7K | ﹤0.01% | 1999 |
|
|
2020
Q3 | $280K | Buy |
18,258
+7,017
| +62% | +$108K | ﹤0.01% | 1938 |
|
|
2020
Q2 | $286K | Buy |
+11,241
| New | +$286K | ﹤0.01% | 1898 |
|